NanoPass Technologies Ltd., a global leader in intradermal delivery solutions, will officially launch MicronJet™ 800 during IMCAS World 2026, taking place January 29 – 31, 2026, in Paris.
The U.S. is now allowing fractional doses of the Jynneos monkeypox vaccine to be administered via an injection that delivers the dose between, rather than under, layers of skin — an effort that will ...
Intradermal administration of the JYNNEOS mpox vaccine is as effective and safe as subcutaneous administration, according to new data released this week by the Centers for Disease Control and ...
The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...
One solution proposed to the current shortage of monkeypox vaccine has been to consider 'dose sparing' to make supplies stretch further. This involves using one vial of the Imvanex/Jynneos vaccine, ...
On May 11, 2023, the World Health Organization announced that mpox (formerly known as monkeypox) was no longer a public health emergency of international concern. However, at approximately the same ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback